Latest Annual Filing

Fiscal Year Ended Dec 31, 2018

View Filing

Stock Information

Company Overview

Axogen (AXGN) is a global leader in innovative surgical solutions for peripheral nerve injuries. Axogen's portfolio of products includes Avance® Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site, AxoGuard® Nerve Connector, a porcine submucosa extracellular matrix ("ECM") coaptation aid for tensionless repair of severed nerves, and AxoGuard® Nerve Protector, a porcine submucosa ECM product used to wrap and protect injured peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Along with these core surgical products, Axogen also offers AxoTouch® Two-Point Discriminator and AcroVal® Neurosensory & Motor Testing System. These evaluation and measurement tools assist healthcare professionals in detecting changes in sensation, assessing return of sensory, grip and pinch function, evaluating effective treatment interventions, and providing feedback to patients on nerve function. The Axogen portfolio of products is available in the United States, Canada, the United Kingdom and several European and international countries.

Corporate Presentation

Corporate Presentation

Download Corporate Presentation


Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information


Axogen, Inc.
13631 Progress Blvd
Suite 400
Alachua, FL 32615

Investor Relations

Axogen, Inc.
13631 Progress Blvd.
Suite 400
Alachua, FL 32615

Transfer Agent

Broadridge Corporate Issuer Solutions, Inc.
1717 Arch St.
Suite 1300
Philadelphia, PA 19103
T: 215-553-5400